Canton Strategic Holdings (CNTN) Non Operating Income (2021 - 2026)

Canton Strategic Holdings (CNTN) reported Non Operating Income of -$14.7 million for Q1 2026, down 296074.34% on a YoY basis from N/an in Q1 2025, and up 33.17% quarter-over-quarter from -$22.0 million in Q4 2025.

Canton Strategic Holdings (CNTN) Non Operating Income (2021 - 2026) Analysis & Trends

Canton Strategic Holdings has reported Non Operating Income for 6 years, with the latest figure at -$14.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income fell 296074.34% year-over-year to -$14.7 million; the trailing twelve-month figure through Mar 2026 stood at -$36.7 million (down 24565.74% YoY), and the FY2025 full-year result was -$22.0 million, down 9412.05% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$14.7 million, up from -$22.0 million in the prior quarter.
  • The five-year high for Non Operating Income was $91194.0 in Q1 2024, with the low at -$22.0 million in Q4 2025.
  • Historically, Non Operating Income has averaged -$2.7 million across 5 years, with a median of $25532.5 in 2023.
  • Annual changes were most pronounced in 2024 — Non Operating Income soared 249.27% — and 2026, when it plunged 296074.34%.
  • Canton Strategic Holdings' Non Operating Income stood at -$1.6 million in 2022, then jumped by 103.61% to $57379.0 in 2023, then sank by 53.09% to $26914.0 in 2024, then tumbled by 81804.72% to -$22.0 million in 2025, then jumped by 33.17% to -$14.7 million in 2026.
  • The last three Non Operating Income figures came in at -$14.7 million (Q1 2026), -$22.0 million (Q4 2025), and -$8260.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Canton Strategic Holdings 699.97 Mn 658.44 Mn - -14.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.70 Mn
Dec 31, 2025 -21.99 Mn
Sep 30, 2025 -8,260.00
Jun 30, 2025 -3,993.00
Mar 31, 2025 4,965.00
Dec 31, 2024 26,914.00
Sep 30, 2024 69,719.00
Jun 30, 2024 48,397.00
Mar 31, 2024 91,194.00
Dec 31, 2023 57,379.00
Sep 30, 2023 24,955.00
Jun 30, 2023 27,682.00
Mar 31, 2023 26,110.00
Mar 31, 2022 -1.59 Mn
Dec 31, 2021 2.55 Mn
Sep 30, 2021 -312,323.00
Jun 30, 2021 -458,371.00
Mar 31, 2021 -782,463.00